Our Mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer.
Working in tandem with our global network of researchers, supporters, patients, and advocates, we're funding the best scientists doing the most promising research—all while promoting awareness, sharing up-to-date immunotherapy information, and inspiring lifelong advocacy for the cause.
We support the science behind the treatment, funding lifesaving immunotherapy research and clinical trials around the world.
Meet Our Scientists
Your trusted resource for the latest credible, accurate cancer immunotherapy information for scientists, patients, and supporters.
Learn How Immunotherapy Works
Join us in the cause to cure all cancers, advancing immunotherapy through events and awareness campaigns.
Create a Fundraising Team
Connecting you to an inspiring network of patients and advocates—that's a crucial part of our mission. See real stories of immunotherapy experiences, or share your own with others looking for insight and information.
Meet Your ImmunoCommunity
We are the Cancer Research Institute, a 501(c)(3) nonprofit organization dedicated to harnessing our immune system's power to control and potentially cure all types of cancer. We fund the most innovative clinical and laboratory research around the world, support the next generation of the field's leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers.
We're working for you—all of our supporters, patients, and scientists—to make the biggest impact possible in supporting cancer immunotherapy research to save more lives.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
A recent diabetes-related discovery by CRI Lloyd J. Old STAR Dr. Andrea Schietinger has promising implications for cancer immunotherapy
Rare and ultra-rare cancers affect around 20,000 people in the United States alone, according to Foundation Medicine, Inc. Immunotherapy research in some of the more common cancers and the identification of biomarkers that can predict patient responses is opening this new approach to cancer treatment up to patients whose cancers currently receive little direct attention.